Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: recount (1), check (1000), verify (25)

Bladder retraining for an overactive bladder - patient information

Description: Information about bladder retraining for an overactive bladder.
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Bladder-retraining-for-an-overactive-bladder-1220-PIL.pdf

Annual-report-2018-19

Description: ANNUAL REPORT AND ACCOUNTS 2018/19 incorporating the quality account 2018/19 Presented to Parliament pursuant to Schedule 7, p
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-2018-19.pdf

Annual report 2021-2022

Description: 2021/22 Incorporating the quality report University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2021/22 Presented to Parliament
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/Annual-report-2021-2022.pdf

Vinorelbine Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER VINORELBINE (INTRAVENOUS) Regimen Breast Cancer – Vinorelbine Indicat
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Vinorelbine-Ver-1.1.pdf

Paclitaxel (21 day)

Description: Chemotherapy Protocol BREAST CANCER PACLITAXEL (21day) Regimen • Breast Cancer – Paclitaxel (21day) Indication • T
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Paclitaxel-21-day.pdf

Cyclophosphamide-Epirubicin-Paclitaxel(7 day)

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXEL (7 day) Regimen • Breast Cancer – Cycl
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Epirubicin-Paclitaxel-7-day.pdf

Cetuximab-Encorafenib

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-ENCORAFENIB Regimen • Colorectal Cancer – Cetuximab-Encorafenib Indication •
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Encorafenib.pdf

Panitumumab (14 day) Ver 1.2

Description: Chemotherapy Protocol COLORECTAL CANCER PANITUMUMAB (14 day) This regimen may require funding Regimen Colore
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Panitumumab14dayVer12.pdf

Feeding information for infants with congenital heart disease

Description: PARENT INFO Information on feeding for infants with congenital heart disease Contents 03 Introduction 0
Url: /Media/UHS-website-2019/Docs/Services/Child-health/DietaryAdvice/Feeding-information-for-infants-with-congenital-heart-disease.pdf

Papers Trust Board - 10 March 2026

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 10/03/2026 9:00 - 13:00 Conference Room, Heartbeat Education
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Papers-Trust-Board-10-March-2026.pdf

61 to 70 of 116

Previous … 5 6 7 8 9 … Next